KIT and intrahepatic cholangiocarcinoma: Presently, by using the same antibody previously used in the human gastrointestinal tract to label the ICC and distinguish them from the PDGFRα/CD34-positive cells, we identified as TC (34), we found c-Kit-positive cells, but all of them were mast cells.